Halofuginone, a promising drug for treatment of pulmonary hypertension is a research paper published in British Journal of Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 20POST35210959
National Institutes of Health
Grant: R01 HL142214
National Institutes of Health
Grant: R01 HL146764
National Institutes of Health
Grant: R35 HL135807
National Institutes of Health
Grant: 5R01HL146764-02
Role of Gap Junction in Hypoxia-induced Pulmonary Hypertension
National Institutes of Health
Grant: 7R01HL142214-06
Coronary Endothelial Cell Dysfunction in Diabetes: Role of MFGE8
National Institutes of Health
Grant: 5R35HL135807-08
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
NHLBI NIH HHS
Grant: R01 HL155945
NHLBI NIH HHS
Grant: R01 HL070852
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals